VANGUARD GROUP INC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 41 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$1,821,000
+4.2%
897,358
-26.5%
0.00%
Q1 2022$1,747,000
-11.0%
1,221,704
+1.4%
0.00%
Q4 2021$1,963,000
-47.3%
1,204,540
+3.2%
0.00%
Q3 2021$3,725,000
-35.1%
1,167,752
+0.5%
0.00%
Q2 2021$5,742,000
+13.2%
1,162,357
+89.0%
0.00%
Q1 2021$5,074,000
+568.5%
615,031
+51.6%
0.00%
Q4 2020$759,000
+571.7%
405,702
+210.5%
0.00%
Q3 2020$113,000
+27.0%
130,668
+43.6%
0.00%
Q2 2020$89,000
-40.3%
90,990
-39.3%
0.00%
Q1 2020$149,000150,0140.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2021
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders